Frank Steven — SEC Form 4 filings
SEC reporting owner CIK 1583886. 14 Form 4 filings on record with FilingPulse; latest filed 2026-09-02.
Transaction summary — filings shown
Covers all 14 filings on record, filed 2024-03-12 to 2026-09-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 27.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| PRECIGEN, INC. (PGEN) | Director | 5 | — | — | 15 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | Director | 9 | — | — | 12 |
Form 4 filings — Frank Steven
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-02 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/award (A): 1,288 @ $9.70 | EDGAR |
| 2026-06-15 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/award (A): 15,294 @ $0 · Grant/award (A): 33,540 (derivative) @ $0 | EDGAR |
| 2026-06-02 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/award (A): 1,262 @ $8.91 | EDGAR |
| 2026-03-16 | 4 | PRECIGEN, INC. (PGEN) | Option exercise (M): 71,839 · Option exercise (M): 71,839 (derivative) @ $0 | EDGAR |
| 2026-03-12 | 4 | PRECIGEN, INC. (PGEN) | Grant/award (A): 14,245 @ $3.51 · Grant/award (A): 35,612 (derivative) @ $0 · Grant/award (A): 41,073 (derivative) @ $0 | EDGAR |
| 2026-03-03 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/award (A): 1,285 @ $8.75 | EDGAR |
| 2025-12-02 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/award (A): 1,566 @ $7.18 | EDGAR |
| 2025-09-03 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/award (A): 1,353 @ $8.31 | EDGAR |
| 2025-06-16 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/award (A): 12,500 @ $0 · Grant/award (A): 27,181 (derivative) @ $0 | EDGAR |
| 2025-06-03 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/award (A): 333 @ $10.75 | EDGAR |
| 2025-05-06 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/award (A): 1,866 @ $0 · Grant/award (A): 4,079 (derivative) @ $0 | EDGAR |
| 2025-03-17 | 4 | PRECIGEN, INC. (PGEN) | Grant/award (A): 28,735 @ $1.74 · Option exercise (M): 87,412 · Grant/award (A): 71,839 (derivative) @ $0 · Option exercise (M): 87,412 (derivative) @ $0 · Grant/award (A): 83,517 (derivative) @ $0 | EDGAR |
| 2024-03-18 | 4 | PRECIGEN, INC. (PGEN) | Grant/award (A): 34,965 @ $1.43 · Grant/award (A): 87,412 (derivative) @ $0 · Grant/award (A): 101,626 (derivative) @ $0 | EDGAR |
| 2024-03-12 | 4 | PRECIGEN, INC. (PGEN) | Option exercise (M): 106,837 · Option exercise (M): 106,837 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1583886 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →